Cargando…
A SelectMDx/magnetic resonance imaging‐based nomogram to diagnose prostate cancer
BACKGROUND: 70%–80% of prostate cancer (PCa) biopsies performed in the US annually may be unnecessary. Specific antigen testing (PSA) and tans rectal ultrasound (TRUS) are imprecise predictive methods for risk of PCa. Novel strategies are critical to guide biopsy decision‐making. AIM: We assessed th...
Autores principales: | Wagaskar, Vinayak G., Levy, Micah, Ratnani, Parita, Sullimada, Sharmila, Gerenia, Mae, Schlussel, Kacie, Choudhury, Samia, Gabriele, Marla, Haas, Ian, Haines, Kenneth, Tewari, Ash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875685/ https://www.ncbi.nlm.nih.gov/pubmed/36168681 http://dx.doi.org/10.1002/cnr2.1668 |
Ejemplares similares
-
A 4K score/MRI‐based nomogram for predicting prostate cancer, clinically significant prostate cancer, and unfavorable prostate cancer
por: Wagaskar, Vinayak G., et al.
Publicado: (2021) -
Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer
por: Visser, Wieke C. H., et al.
Publicado: (2022) -
Clinical Utility of Negative Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer and Clinically Significant Prostate Cancer
por: Wagaskar, Vinayak G., et al.
Publicado: (2021) -
Can the predictive value of multiparametric MRI for prostate cancer be improved by a liquid biopsy with SelectMDx?
por: Rahnama'i, Mohammad Sajjad, et al.
Publicado: (2021) -
Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
por: Chakravarty, Dimple, et al.
Publicado: (2020)